FDA Warns Consumers against Use of Meizi Weight Loss Drug

FDA Warns Consumers against Use of Meizi Weight Loss Drug
September 9, 2015

A weight loss supplement containing a dangerous substance is drawing the ire of one government agency.

Last week, the U.S. Food and Drug Administration (FDA) issued a warning advising consumers not to purchase or use Meizi Super Power Fruits Herbal Slimming Formula. The product is sold by Slim East USA Diet Supplements.

Meizi contains sibutramine, a substance that was banned from the American market in October 2010. Sibutramine is known to substantially increase blood pressure and/or pulse rate in some patients and may present a significant risk for patients with a history of coronary artery disease, congestive heart failure, arrhythmias, or stroke. These products may also interact, in life-threatening ways, with other medications a consumer may be taking.

The FDA notes a growing trend of dietary supplements with hidden drugs and chemicals being available to consumers. These products are typically promoted for sexual enhancement, weight loss, and body building and are often represented as being "all natural."

The FDA is unable to test and identify all products marketed as dietary supplements that have potentially harmful hidden ingredients. Consumers should exercise caution before purchasing any product in the above categories.